News Releases

Emil Lou

Emil Lou, MD, PhD, FACP, Assistant Professor of Medicine, Division of Hematology, Oncology, and Transplantation (HOT), has been appointed Medical Director of the Masonic Cancer Center Clinical Trials Office (CTO). This new role will begin on September 1, 2019.


MINNEAPOLIS - A team led by Reuben Harris, PhD, Professor in the Department of Biochemistry, Molecular Biology, and Biophysics (BMBB), and Douglas Yee, MD, Director of the Masonic Cancer Center, and Professor in the Department of Medicine and Pharmacology, were recently awarded a multi-million dollar program project grant P01 from the National Cancer Institute (NCI). 

Shernan Holtan

Shernan Holtan, MD, Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation and a Hematologist/Oncologist with University of Minnesota Health, was appointed as the Medical Director of the Masonic Cancer Center Clinical Trials Office-Cellular, Gene and Immunotherapy (CTO-CGI) earlier this year.

Andrew Venteicher

MINNEAPOLIS/ST. PAUL (July 23, 2019) – Distinguished surgeon-scientist, Andrew Venteicher, MD, PhD, has joined the University of Minnesota Medical School’s Department of Neurosurgery and the Masonic Cancer Center, where he will be leading key research initiatives in the genomics of brain tumors as the Director of Center for Cranial Base Surgery.  

PanCAN logo

The Pancreatic Cancer Action Network (PanCAN) announced the recipients of its 2019 research grants. Through a highly competitive peer-review process, seven researchers across the U.S. were selected, bringing PanCAN’s total projected research investment to approximately $104 million, including its grants program and clinical and scientific initiatives.

As part of the Masonic Cancer Center's Internal Grant Awards, the 2019 Chainbreaker GOpher a Cure Awards were recently announced. 
Anne Blaes

There are more than 15 million cancer survivors in the world today, each living with the systemic impacts of their cancer treatments. Survivorship research focuses on the myriad of issues cancer treatments cause and seeks to maximize patient quality of life after the therapy.

Hormel Institute

Study of chromosome abnormalities reveals link to cancer

(Austin, Minnesota) – The Hormel Institute, University of Minnesota announces newly published research concerning remnants of ancient viruses found in human chromosomes and how this may affect the risk of developing cancer and other diseases.